Open AccessVirologic and Serologic Outcomes of Mono Versus Dual HBV Therapy and Characterization of HIV/HBV Coinfection in a US Cohort
Author(s) -
Min-Hee Kang,
Kimberly Hollabaugh,
Vinh Pham,
Susan L. Koletar,
Kun Wu,
Marlene Smurzynski,
Judith A. Aberg
Publication year - 2014
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000000149
Subject(s) - hbeag , lamivudine , coinfection , hepatitis b virus , medicine , emtricitabine , hepatitis b , virology , serology , viral load , immunology , gastroenterology , hbsag , antibody , virus
To characterize HIV/hepatitis B virus (HBV) coinfection in the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials cohort and compare long-term HBV outcomes between regimens with 1 (MONO) or 2 (DUAL) anti-HBV agents.